Shijiazhuang Dingmin pharmaceutical Sciences Co.,Ltd
sales@dingminpharma.com
86-311-67260775
Modelo: 1038915-60-4
marca: Dm
Appearance: Powder
Pacote: PE duplo com sacola de alumínio
produtividade: 100kg/month
transporte: Ocean,Air
Lugar de origem: Hebei, China
Apoio sobre: 100kg/month
Certificados : ISO9001
porta: Shanghai
Tipo de pagamento: L/C,T/T
Incoterm: FOB,CIF
O Niraparib é um inibidor de PARP de pequenas moléculas por via oral desenvolvido por Tesaro para tratar o câncer de ovário.
O niraparibe é usado para o tratamento de manutenção de pacientes adultos com ovário epitelial recorrente, tubo de falópio ou câncer peritoneal primário que estão em resposta completa ou parcial à quimioterapia à base de platina.
|
Test Items |
Specification |
Test Results |
|
Appearance |
White powder |
White powder |
|
Melting point |
125~127°C |
Conforms |
|
Specific Rotation |
+28°~+30° |
+29° |
|
Acidity(PH) |
5.2~6.5 |
5.8~6.2 |
|
Water |
4.0%~5.5% |
5.0% |
|
Residue On Ignition |
Not more than 0.1% |
Conforms |
|
N.N - dimethylaniline |
Comply with the standard |
Conforms |
|
Phenolic Compounds |
Comply with the standard |
Conforms |
|
Related Substance |
Comply with the standard |
Conforms |
|
Assay |
Between99.0~102.0% |
99.53% |
|
Conclusion |
This batch is complies with USP 41 |
|
Grupo de Produto : APIs e intermediários > APIs em pó
Privacy statement: Your privacy is very important to Us. Our company promises not to disclose your personal information to any external company with out your explicit permission.
Fill in more information so that we can get in touch with you faster
Privacy statement: Your privacy is very important to Us. Our company promises not to disclose your personal information to any external company with out your explicit permission.
Contact Now